-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse NasdaqUSDISIN US67577C1053-
EUROcugen IncBörse Börse Frankfurt
-
EUROcugen IncBörse Börse Berlin
-
OCUGEN INCBörse Börse HamburgEURSymbol 2H51
-
OCUGEN INCBörse Gettex System der Börse MünchenEURSymbol 2H51
-
OCUGEN INCBörse Quotrix System der Börse DüsseldorfEURSymbol 2H51
-
OCUGEN INCBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol 2H51
-
Ocugen IncBörse NasdaqISIN US67577C1053 WKN: A2PSZHUSDSymbol OCGN
-
ISIN US67577C1053 WKN: A2PSZHUSDSymbol OCGN
-
MXN
-
ISIN US67577C1053
WKN A2PSZH
Symbol OCGN
Währung
USD
Börse
Nasdaq Zeitzone: America/Mexico_City
Firmenname
Ocugen, Inc
Marktkapitalisierung
2.426.421.568 (+- 21%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
1.922.843.136 oder 2.930.000.000
Mitarbeiter
50 (+- 68%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
16 oder 84 Mitarbeiter
KGV
0.08
EBITDA -15.215.256
PEGRatio None
Buchwert None
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 2,23 USD +2,34%
Dir gefallen die Informationen zu Ocugen Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Ocugen Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Ocugen Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Ocugen Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
113 News & Informationen zur Ocugen Inc Aktie
Glancy Prongay & Murray LLP : Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ocugen, Inc. (OCGN)
Investors with losses exceeding $100,000 are encouraged to contact the firm
… | June 25, 2021
Hot Penny Stocks to Buy in 2021? Check These 7 Out Right Now
Top Stocks To Buy This Week? 4 Health Care Stocks To Watch
Check out these trending names in the health care industry.
Why Ocugen Climbed 8% Higher Today
The company will join a rarefied club starting early next week.
Deadline Reminder: Law Offices Of Howard G. Smith Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Ocugen, Inc. (OCGN)
Law Offices of Howard G. Smith reminds investors of the upcoming August 16, 2021deadline to file a lead plaintiff motion in the case filed on behalf of
8 Hot Biotech Penny Stocks For Your July 2021 Watch List
LAWSUIT FILED: Ocugen Sued for Violations of Federal Securities Laws; Investors Should Contact Block & Leviton
BOSTON, June 23, 2021 (GLOBE NEWSWIRE) — Block & Leviton announces that a lawsuit for violations of federal securities laws has been filed against…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Ocugen, Inc. – OCGN
NEW YORK, June 22, 2021 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ:
Portnoy Law: Lawsuit Filed On Behalf of Ocugen, Inc. Investors
Click here to join the case LOS ANGELES, June 22, 2021 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises investors that a class action lawsuit has been…
What's Next For Ocugen Stock As It Bounces Off Support?
Ocugen Inc. (NASDAQ:OCGN) shares are trading lower Tuesday, likely making a correction after shares saw a nice gain Monday. Ocugen was down 5.14%…
3 Obscenely Overpriced Stocks I Wouldn't Buy Even if the Market Crashes
A lower price won't address these other risks.
SHAREHOLDER ALERT: Robbins LLP Announces That Ocugen, Inc. (OCGN) Is Being Sued For Misleading Shareholders
Shareholder rights law firm Robbins LLP announces that a class action has been filed on behalf of all purchasers of Ocugen, Inc. OCGN who acquired Ocugen
Ocugen, Inc. Announces Ken Inchausti as Head, Investor Relations & Communications
MALVERN, Pa., June 21, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and…
3 Robinhood Stocks That Have More Than Doubled in 2021: Are They Buys Now?
These stocks are red-hot so far this year. But could they cool off in the coming months?
5 Stocks That Made People Millionaires in 6 Months
With gains of 1,259% to 2,801%, these billion-dollar stocks have been unstoppable since early October.
FDA Expands Approved Use Of PFE's Xalkori, LXRX Soars On Sotagliflozin Update, BCYC Hits New High
Today's Daily Dose brings you news about Lexicon's regulatory update on Sotagliflozin in heart failure; FDA approval of Pfizer's XALKORI in a new indication; Bicycle's pipeline progress update and Organogenesis' progress in knee osteoarthritis trial.
Why Ocugen Stock Is Sinking Today
The biotech unexpectedly canceled a stockholder meeting scheduled for Wednesday.
Stocks of Note for Jan-12 Morning
Ocugen Inc. Regains Compliance with Nasdaq Bid Price Rule
MALVERN, Pa., Jan. 08, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ:OCGN), a biopharmaceutical company focused on discovering, developing, and …
Pre-market Movers In Healthcare Sector: MRUS, OGEN, JAGX, CVAC, SRPT…
What's moving these stocks in pre-market hours today?.
Ocugen : Corporate Deck
sets clear path for critical manufacturing
OCU200: Targeting major retinal diseases: Diabetic Macular Edema , Diabetic Retinopathy , and Wet Age- Related… | January 6, 2021
Pre-market Movers In Healthcare Sector: CHEK, SYN, NSPR, ZOM, BNGO, VRAY…
What’s moving these stocks in pre-market hours today?.
CALA Falls As CANTATA Trial Fails, Haven Healthcare To Be Disbanded, MTNB Awaits MAT9001 Data In Q1
Today’s Daily Dose brings you news about Pandion’s phase Ia trial of autoimmune disease drug PT101 in healthy volunteers; Matinas BioPharma’s anticipated milestone for this quarter; Calithera’s disappointing results from phase II study of Telaglenastat in patients with renal cell carcinoma, Provention Bio’s near-term regulatory catalyst; and disbanding of Haven Healthcare joint venture.
CALA Falls As CANTATA Trial Fails, Haven Healthcare To Be Disbanded, MTNB Awaits MAT9001 Data In Q1
(RTTNews) – Today’s Daily Dose brings you news about Pandion’s phase Ia trial of autoimmune disease drug PT101 in healthy volunteers; Matinas BioP…
Mid-Afternoon Market Update: Dow Tumbles Over 500 Points; Calithera Biosciences Shares Slide
Toward the end of trading Monday, the Dow traded down 1.77% to 30,065.47 while the NASDAQ fell 1.83% to 12,652.84. The S&P also fell, dropping 1.83% to …
Stocks That Hit 52-Week Highs On Monday
During Monday’s morning session, 286 stocks hit new 52-week highs.
Areas of Interest: The company with the largest market cap to set a new …
Why Calithera, BioNano Genomics And More Are Moving Today
Calithera Biosciences (NASDAQ: CALA) shares are trading lower after the company announced that its CANTATA study of Telaglenastat in Renal Cell Carcinoma …
Mid-Day Market Update: Crude Oil Down Over 2%; The9 Shares Spike Higher
Midway through trading Monday, the Dow traded down 1.72% to 30,080.25 while the NASDAQ fell 1.43% to 12,703.53. The S&P also fell, dropping 1.59% to …
5 Value Stocks In The Healthcare Sector
What are Value Stocks?
A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that …
OCGN Stock: Why Ocugen Shares Are Soaring 70% Today
OCGN stock is soaring Monday thanks to news that Covid-19 vaccine partner has received the green light in India.
Ocugen (OCGN) Stock: Here’s Why Ocugen Is Rocketing
OCGN stock is screaming for the top in the market this morning as investors cheer stockholder meeting results and COVID-19 efforts.
12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers Ocugen (NASDAQ:OCGN) stock rose 122.41% to $4.07 during Monday’s pre-market session. The market value of their outstanding shares is at …
35 Stocks Moving in Monday’s Pre-Market Session
Gainers Ocugen, Inc. (NASDAQ:OCGN) shares rose 121.8% to $4.06 in pre-market trading after the company’s partner Bharat Biotech received E…
35 Stocks Moving in Monday’s Pre-Market Session
Gainers Ocugen, Inc. (NASDAQ: OCGN) shares rose 121.8% to $4.06 in pre-market trading after the company’s partner Bharat Biotech received EUA for …
Pre-market Movers In Healthcare Sector: OCGN, BNGO, JAGX, IMMP, SLLS…
What’s moving these stocks in pre-market hours today?.
Pre-market Movers In Healthcare Sector: OCGN, BNGO, JAGX, IMMP, SLLS…
(RTTNews) – What’s moving these stocks in pre-market hours today? In the Green 1. Ocugen Inc. (OCGN) is up nearly 79% at $3.29 in pre-market hou…
India’s approval of homegrown vaccine criticised over lack of data
India on Sunday granted emergency approval to Bharat Biotech’s COVAXIN but faced questions from industry experts and opposition lawmakers after taking the step without publishing efficacy data for… | January 3, 2021
India’s nod to indigenous vaccine condemned over lack of data released on efficacy
India on Sunday granted emergency approval to Bharat Biotech’s COVAXIN but faced questions after taking the step without publishing efficacy data for the homegrown coronavirus vaccine
Timeline: India’s coronavirus vaccine approved by drugs experts
India’s drugs regulator on Saturday recommended for emergency use a locally developed coronavirus vaccine called COVAXIN, which is expected to be a backup to the AstraZeneca/Oxford shot…. | January 3, 2021
TIMELINE-India’s coronavirus vaccine approved by drugs experts
India’s drugs regulator
on Saturday recommended for emergency use a locally developed
coronavirus vaccine called COVAXIN, which is expected to be a
backup to the AstraZeneca/Oxford shot.
… | January 2, 2021